Cargando…

Cerebrovascular Risk Factors in Possible or Probable Cerebral Amyloid Angiopathy, Modifier or Bystander?

Goal: Cerebral amyloid angiopathy (CAA) is a frequent cause of atypical intracerebral hemorrhage (ICH) in the elderly. Stroke risk factors such as arterial hypertension (AHT), atrial fibrillation (AFib), diabetes mellitus (DM), and renal dysfunction (RD) are increasingly apparent in these patients....

Descripción completa

Detalles Bibliográficos
Autores principales: Wagner, Andrea, Maderer, Jonas, Wilfling, Sibylle, Kaiser, Johanna, Kilic, Mustafa, Linker, Ralf A., Schebesch, Karl-Michael, Schlachetzki, Felix
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8335403/
https://www.ncbi.nlm.nih.gov/pubmed/34354659
http://dx.doi.org/10.3389/fneur.2021.676931
_version_ 1783733096007335936
author Wagner, Andrea
Maderer, Jonas
Wilfling, Sibylle
Kaiser, Johanna
Kilic, Mustafa
Linker, Ralf A.
Schebesch, Karl-Michael
Schlachetzki, Felix
author_facet Wagner, Andrea
Maderer, Jonas
Wilfling, Sibylle
Kaiser, Johanna
Kilic, Mustafa
Linker, Ralf A.
Schebesch, Karl-Michael
Schlachetzki, Felix
author_sort Wagner, Andrea
collection PubMed
description Goal: Cerebral amyloid angiopathy (CAA) is a frequent cause of atypical intracerebral hemorrhage (ICH) in the elderly. Stroke risk factors such as arterial hypertension (AHT), atrial fibrillation (AFib), diabetes mellitus (DM), and renal dysfunction (RD) are increasingly apparent in these patients. In this retrospective study, we analyzed the presence of these stroke risk factors in different initial CAA presentations comprising cerebral microbleeds (CMB), acute ischemic stroke (AIS), cortical superficial hemosiderosis (cSS), or lobar ICH (LICH) and evaluated their influence on the initial clinical presentation of patients with CAA. Material and Methods: We identified patients with at least possible CAA defined by the modified Boston criteria admitted to the Department of Neurology or Neurosurgery from 2002 to 2018. Findings: In the overall cohort of 209 patients, we analyzed the correlation between the number of stroke risk factors and the initial clinical presentation of patients with CAA and could show the high multimorbidity of the collective. There are large differences between the subgroups with different initial clinical presentations, e.g., patients with CMB as initial CAA presentation have the highest number of cerebrovascular risk factors and recurrent AIS, whereas AFib is more frequent in the Neurosurgery Department. Conclusion: There is a distinct overlap between the subgroups of CAA manifestations and stroke risk factors that need to be verified in larger patient collectives. Since these comorbidities are likely to influence the clinical course of CAA, they represent possible targets for secondary prevention until specific treatment for CAA becomes available.
format Online
Article
Text
id pubmed-8335403
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-83354032021-08-04 Cerebrovascular Risk Factors in Possible or Probable Cerebral Amyloid Angiopathy, Modifier or Bystander? Wagner, Andrea Maderer, Jonas Wilfling, Sibylle Kaiser, Johanna Kilic, Mustafa Linker, Ralf A. Schebesch, Karl-Michael Schlachetzki, Felix Front Neurol Neurology Goal: Cerebral amyloid angiopathy (CAA) is a frequent cause of atypical intracerebral hemorrhage (ICH) in the elderly. Stroke risk factors such as arterial hypertension (AHT), atrial fibrillation (AFib), diabetes mellitus (DM), and renal dysfunction (RD) are increasingly apparent in these patients. In this retrospective study, we analyzed the presence of these stroke risk factors in different initial CAA presentations comprising cerebral microbleeds (CMB), acute ischemic stroke (AIS), cortical superficial hemosiderosis (cSS), or lobar ICH (LICH) and evaluated their influence on the initial clinical presentation of patients with CAA. Material and Methods: We identified patients with at least possible CAA defined by the modified Boston criteria admitted to the Department of Neurology or Neurosurgery from 2002 to 2018. Findings: In the overall cohort of 209 patients, we analyzed the correlation between the number of stroke risk factors and the initial clinical presentation of patients with CAA and could show the high multimorbidity of the collective. There are large differences between the subgroups with different initial clinical presentations, e.g., patients with CMB as initial CAA presentation have the highest number of cerebrovascular risk factors and recurrent AIS, whereas AFib is more frequent in the Neurosurgery Department. Conclusion: There is a distinct overlap between the subgroups of CAA manifestations and stroke risk factors that need to be verified in larger patient collectives. Since these comorbidities are likely to influence the clinical course of CAA, they represent possible targets for secondary prevention until specific treatment for CAA becomes available. Frontiers Media S.A. 2021-07-21 /pmc/articles/PMC8335403/ /pubmed/34354659 http://dx.doi.org/10.3389/fneur.2021.676931 Text en Copyright © 2021 Wagner, Maderer, Wilfling, Kaiser, Kilic, Linker, Schebesch and Schlachetzki. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neurology
Wagner, Andrea
Maderer, Jonas
Wilfling, Sibylle
Kaiser, Johanna
Kilic, Mustafa
Linker, Ralf A.
Schebesch, Karl-Michael
Schlachetzki, Felix
Cerebrovascular Risk Factors in Possible or Probable Cerebral Amyloid Angiopathy, Modifier or Bystander?
title Cerebrovascular Risk Factors in Possible or Probable Cerebral Amyloid Angiopathy, Modifier or Bystander?
title_full Cerebrovascular Risk Factors in Possible or Probable Cerebral Amyloid Angiopathy, Modifier or Bystander?
title_fullStr Cerebrovascular Risk Factors in Possible or Probable Cerebral Amyloid Angiopathy, Modifier or Bystander?
title_full_unstemmed Cerebrovascular Risk Factors in Possible or Probable Cerebral Amyloid Angiopathy, Modifier or Bystander?
title_short Cerebrovascular Risk Factors in Possible or Probable Cerebral Amyloid Angiopathy, Modifier or Bystander?
title_sort cerebrovascular risk factors in possible or probable cerebral amyloid angiopathy, modifier or bystander?
topic Neurology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8335403/
https://www.ncbi.nlm.nih.gov/pubmed/34354659
http://dx.doi.org/10.3389/fneur.2021.676931
work_keys_str_mv AT wagnerandrea cerebrovascularriskfactorsinpossibleorprobablecerebralamyloidangiopathymodifierorbystander
AT madererjonas cerebrovascularriskfactorsinpossibleorprobablecerebralamyloidangiopathymodifierorbystander
AT wilflingsibylle cerebrovascularriskfactorsinpossibleorprobablecerebralamyloidangiopathymodifierorbystander
AT kaiserjohanna cerebrovascularriskfactorsinpossibleorprobablecerebralamyloidangiopathymodifierorbystander
AT kilicmustafa cerebrovascularriskfactorsinpossibleorprobablecerebralamyloidangiopathymodifierorbystander
AT linkerralfa cerebrovascularriskfactorsinpossibleorprobablecerebralamyloidangiopathymodifierorbystander
AT schebeschkarlmichael cerebrovascularriskfactorsinpossibleorprobablecerebralamyloidangiopathymodifierorbystander
AT schlachetzkifelix cerebrovascularriskfactorsinpossibleorprobablecerebralamyloidangiopathymodifierorbystander